Benzodiazepine deprescribing
1 paper1 finding
- 1 lab in 1 country
- Humans1
Outcomes
1Mortality
no changein humans1HR 0.97
1 study
Mortality
no changein humans1HR 0.97
Benzodiazepine deprescribing has no effect on mortality in humans (HR 0.97, 95% CI 0.68-1.39).
“Conversely, patients in whom BZDs were deprescribed during hospitalization (n = 179) exhibited a similar mortality risk as nonusers (HR: 0.97; 95% CI: 0.68-1.39).”
Humans6 months
The journals of gerontology. Series A, Biological sciences and medical sciences24 Nov 2025
Latest
1 in 12 monthsThe Journals of Gerontology, Series A
Benzodiazepine exposure and 6-month mortality in older adults post-hospitalization: time to consider deprescribing?
Cohort study of 1,375 peoplePopulations